Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2019 Jul;28(7):1238-1245.
doi: 10.1158/1055-9965.EPI-18-1235. Epub 2019 Apr 23.

Analysis of Heritability and Genetic Architecture of Pancreatic Cancer: A PanC4 Study

Affiliations
Multicenter Study

Analysis of Heritability and Genetic Architecture of Pancreatic Cancer: A PanC4 Study

Fei Chen et al. Cancer Epidemiol Biomarkers Prev. 2019 Jul.

Abstract

Background: Pancreatic cancer is the fourth-leading cause of cancer death in both men and women in the United States. The currently identified common susceptibility loci account for a small fraction of estimated heritability. We sought to estimate overall heritability of pancreatic cancer and partition the heritability by variant frequencies and functional annotations.

Methods: Analysis using the genome-based restricted maximum likelihood method (GREML) was conducted on Pancreatic Cancer Case-Control Consortium (PanC4) genome-wide association study (GWAS) data from 3,568 pancreatic cancer cases and 3,363 controls of European Ancestry.

Results: Applying linkage disequilibrium- and minor allele frequency-stratified GREML (GREML-LDMS) method to imputed GWAS data, we estimated the overall heritability of pancreatic cancer to be 21.2% (SE = 4.8%). Across the functional groups (intronic, intergenic, coding, and regulatory variants), intronic variants account for most of the estimated heritability (12.4%). Previously identified GWAS loci explained 4.1% of the total phenotypic variation of pancreatic cancer. Mutations in hereditary pancreatic cancer susceptibility genes are present in 4% to 10% of patients with pancreatic cancer, yet our GREML-LDMS results suggested these regions explain only 0.4% of total phenotypic variance for pancreatic cancer.

Conclusions: Although higher than previous studies, our estimated 21.2% overall heritability may still be downwardly biased due to the inherent limitation that the contribution of rare variants in genes with a substantive overall impact on disease are not captured when applying these commonly used methods to imputed GWAS data.

Impact: Our work demonstrated the importance of rare and common variants in pancreatic cancer risk.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: The authors declare no potential conflicts of interest.

Figures

Figure 1.
Figure 1.. Minor allele frequency (MAF) and functional annotation of PanC4 imputed variants.
A, MAF distribution of imputed variants passed all quality control filters showed that majority of these variants had a MAF < 0.05. B, Imputed variants were annotated into six functional groups by ANNOVA, among which intergenic (52.7%) and intronic (37.2%) variants were the two largest groups.
Figure 2.
Figure 2.. Estimated variance explained by imputed variants on individual chromosome stratified by MAF and LD.
Variants on each chromosome were stratified into 2 MAF categories and 2 LD groups. The estimated variance associated with individual chromosome was aggregated from the variance explained by four MAF-LD groups. This analysis ranks chromosome 9, 7, 16, 8, 5, 2 and 1 as top contributors to the estimated heritability.
Figure 3.
Figure 3.. Estimated variance explained by imputed variants stratified by MAF.
Variants were stratified into six minor allele frequency (MAF) categories: < 0.01, 0.01–0.10, 0.10–0.20, 0.20–0.30, 0.30–0.40 and ≥0.40. Across the MAF categories, rare variants with MAF < 0.01 accounts for the most variance, followed by variants with MAF ranged from 0.01 to 0.10

References

    1. Ilic M, Ilic I. Epidemiology of pancreatic cancer. World J Gastroenterol. 2016. November 28;22(44):9694–705. - PMC - PubMed
    1. Cancer Facts & Figures 2018. [Internet]. [cited 2018 April 25]. Available from: https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-...
    1. Rahib L, Smith BD, Aizenberg R, Rosenzweig AB, Fleshman JM, Matrisian LM. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res. 2014. June 1;74(11):2913–21. - PubMed
    1. Shindo K, Yu J, Suenaga M, Fesharakizadeh S, Cho C, Macgregor-Das A, et al. Deleterious Germline Mutations in Patients With Apparently Sporadic Pancreatic Adenocarcinoma. J Clin Oncol Off J Am Soc Clin Oncol. 2017. October 20;35(30):3382–90. - PMC - PubMed
    1. Hu C, Hart SN, Polley EC, Gnanaolivu R, Shimelis H, Lee KY, et al. Association Between Inherited Germline Mutations in Cancer Predisposition Genes and Risk of Pancreatic Cancer. JAMA. 2018. June 19;319(23):2401–9. - PMC - PubMed

Publication types